What is AtriClip?

What is AtriClip?

The AtriClip, which is applied to the outside surface of the left atrial appendage, permanently closes the left atrial appendage at its base, preventing blood from entering the pouch. This procedure is performed by a cardiac surgeon using minimally invasive surgical techniques.

What is the AtriClip made of?

The Atriclip is made of a two polyester-covered parallel tubes with nitinol springs ([Figure 1C]).

Is the AtriClip FDA approved?

The U.S. Food and Drug Administration (FDA) has approved the AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion system for atrial fibrillation patients undergoing open heart surgery. When blood is caught in the left atrial appendage, clots can form.

What is a Lariat procedure?

The LARIAT procedure —also called left atrial appendage (LAA) closure — is a minimally invasive, nonsurgical procedure that can help prevent stroke in people with atrial fibrillation (AFib) who cannot take blood-thinning medication.

Who makes the AtriClip?

AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date. For more information, visit AtriCure.com or follow us on Twitter @ AtriCure .

Is the Lariat procedure FDA approved?

The LARIAT system device is approved by the FDA for soft tissue closure (approximation) only, but not specifically for prevention of thromboembolism with LAA occlusion. The safety and efficacy of the LARIAT procedure were reported in several observational studies.

Is watchman better than warfarin?

Both NOACs and Watchman were superior to warfarin in hemorrhagic stroke prevention (OR = 0.46 [0.30-0.82] and OR = 0.21 [0.05-0.99], respectively). NOACs significantly reduced total stroke (OR = 0.78 [0.58-0.96]) and major bleeding (OR = 0.78 [0.65-0.91]) compared with warfarin.